Roberto Badagliacca

10.5k total citations · 1 hit paper
138 papers, 2.4k citations indexed

About

Roberto Badagliacca is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Roberto Badagliacca has authored 138 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Cardiology and Cardiovascular Medicine, 96 papers in Pulmonary and Respiratory Medicine and 17 papers in Surgery. Recurrent topics in Roberto Badagliacca's work include Pulmonary Hypertension Research and Treatments (90 papers), Cardiovascular Function and Risk Factors (51 papers) and Heart Failure Treatment and Management (34 papers). Roberto Badagliacca is often cited by papers focused on Pulmonary Hypertension Research and Treatments (90 papers), Cardiovascular Function and Risk Factors (51 papers) and Heart Failure Treatment and Management (34 papers). Roberto Badagliacca collaborates with scholars based in Italy, United States and United Kingdom. Roberto Badagliacca's co-authors include Robert Naeije, Carmine Dario Vizza, Susanna Sciomer, Roberto Poscia, Silvia Papa, Francesco Fedele, Beatrice Pezzuto, Michele D’Alto, Elisa Giannetta and Giovanna Manzi and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Roberto Badagliacca

127 papers receiving 2.4k citations

Hit Papers

SGLT2i Reduce Arrhythmic Events in Heart Failure Patients... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SGLT2i Reduce Arrhythmic Events in Heart Failure Patients with Cardiac Implantable Electronic Devices
    2025 17 citations Marco Valerio Mariani, Carlo Lavalle et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Badagliacca Italy 28 1.7k 1.5k 362 358 177 138 2.4k
Laura Scelsi Italy 28 2.1k 1.2× 1.4k 1.0× 337 0.9× 285 0.8× 311 1.8× 105 2.9k
Edmund Lau Australia 26 1.2k 0.7× 2.3k 1.6× 330 0.9× 242 0.7× 237 1.3× 89 2.7k
Henning Gall Germany 30 2.2k 1.3× 2.7k 1.8× 406 1.1× 352 1.0× 206 1.2× 139 3.4k
Michele D’Alto Italy 33 2.5k 1.5× 2.7k 1.9× 493 1.4× 882 2.5× 124 0.7× 152 3.6k
Karl Dujardin Belgium 17 2.7k 1.6× 1.5k 1.0× 572 1.6× 591 1.7× 165 0.9× 41 3.2k
François Kerbaul France 27 1.3k 0.8× 1.1k 0.7× 822 2.3× 352 1.0× 107 0.6× 113 2.3k
Frédéric Bodin France 19 920 0.5× 1.2k 0.8× 396 1.1× 138 0.4× 118 0.7× 43 1.9k
Elke S. Hoendermis Netherlands 29 2.1k 1.3× 1.5k 1.0× 443 1.2× 1.0k 2.8× 146 0.8× 74 2.7k
Takeyoshi Kunieda Japan 17 1.0k 0.6× 1.0k 0.7× 239 0.7× 238 0.7× 76 0.4× 60 1.6k
Jaap J. Kloek Netherlands 29 1.1k 0.7× 1.8k 1.2× 1.2k 3.3× 290 0.8× 83 0.5× 59 2.7k

Countries citing papers authored by Roberto Badagliacca

Since Specialization
Citations

This map shows the geographic impact of Roberto Badagliacca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Badagliacca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Badagliacca more than expected).

Fields of papers citing papers by Roberto Badagliacca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Badagliacca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Badagliacca. The network helps show where Roberto Badagliacca may publish in the future.

Co-authorship network of co-authors of Roberto Badagliacca

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Badagliacca. A scholar is included among the top collaborators of Roberto Badagliacca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Badagliacca. Roberto Badagliacca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badagliacca, Roberto, et al.. (2025). Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted Therapy. International Journal of Molecular Sciences. 26(19). 9700–9700.
2.
D’Amato, Andrea, Silvia Prosperi, Francesca Ferranti, et al.. (2025). Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF. American Journal of Cardiovascular Drugs. 26(2). 205–214.
3.
Prosperi, Silvia, Andrea D’Amato, Lucrezia Netti, et al.. (2024). Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature. International Journal of Molecular Sciences. 25(21). 11458–11458. 3 indexed citations
4.
Correale, Michele, Lucia Tricarico, Michele D’Alto, et al.. (2024). Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside. Journal of Clinical Medicine. 13(8). 2444–2444. 11 indexed citations
5.
D’Amato, Andrea, Silvia Prosperi, Paolo Severino, et al.. (2024). MicroRNA and Heart Failure: A Novel Promising Diagnostic and Therapeutic Tool. Journal of Clinical Medicine. 13(24). 7560–7560. 8 indexed citations
6.
Spaziani, Matteo, Francesco Carlomagno, C Tarantino, et al.. (2024). From Klinefelter Syndrome to High Grade Aneuploidies: Expanding the Gene-dosage Effect of Supernumerary X Chromosomes. The Journal of Clinical Endocrinology & Metabolism. 109(8). e1564–e1573. 8 indexed citations
7.
White, R. James, Karim El‐Kersh, Stephan Rosenkranz, et al.. (2024). Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities. CHEST Journal. 167(6). 1746–1758. 1 indexed citations
8.
Scelsi, Laura, Roberto Badagliacca, Livio Giuliani, et al.. (2024). Real-world evidence on pulmonary arterial hypertension: interim analysis from the Italian observational study INSPECTIO. European Heart Journal. 45(Supplement_1).
9.
Severino, Paolo, Andrea D’Amato, Silvia Prosperi, et al.. (2024). Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience. American Journal of Cardiovascular Drugs. 24(5). 663–671. 4 indexed citations
10.
Capoccia, Massimo, et al.. (2023). IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study. Journal of Cardiovascular Development and Disease. 10(4). 140–140. 5 indexed citations
11.
Severino, Paolo, Andrea D’Amato, Massimo Mancone, et al.. (2023). Protection against Ischemic Heart Disease: A Joint Role for eNOS and the KATP Channel. International Journal of Molecular Sciences. 24(9). 7927–7927. 3 indexed citations
12.
Madonna, Rosalinda, Mattia Alberti, Riccardo Morganti, et al.. (2023). Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time. European Journal of Internal Medicine. 123. 120–126. 3 indexed citations
13.
Yogeswaran, Athiththan, Zvonimir A. Rako, Hossein Ardeschir Ghofrani, et al.. (2023). Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension. ERJ Open Research. 9(5). 226–2023. 13 indexed citations
14.
Iacovoni, Attilio, Massimo Capoccia, Silvia Papa, et al.. (2022). Ventricular and Atrial Pressure—Volume Loops: Analysis of the Effects Induced by Right Centrifugal Pump Assistance. Bioengineering. 9(5). 181–181. 4 indexed citations
15.
Benza, Raymond L., David Langleben, Anna R. Hemnes, et al.. (2022). Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. European Respiratory Review. 31(166). 220061–220061. 10 indexed citations
16.
Papa, Silvia, Giovanna Manzi, Susanna Sciomer, et al.. (2021). Peripheral Arterial Stiffness in Acute Pulmonary Embolism and Pulmonary Hypertension at Short-Term Follow-Up. Journal of Clinical Medicine. 10(14). 3008–3008. 2 indexed citations
17.
Badagliacca, Roberto, Roberto Poscia, Beatrice Pezzuto, et al.. (2017). Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 37(2). 195–205. 47 indexed citations
18.
Badagliacca, Roberto, Silvia Papa, Gabriele Valli, et al.. (2017). Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension. European Respiratory Journal. 49(6). 1601419–1601419. 37 indexed citations
19.
Pofi, Riccardo, Daniele Gianfrilli, Roberto Badagliacca, et al.. (2015). Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?. Journal of Endocrinological Investigation. 39(2). 131–142. 21 indexed citations
20.
Vizza, Carmine Dario, Claudio Letizia, Roberto Badagliacca, et al.. (2005). BASELINE VENOUS ENDOTHELIN-1 (ET1) PLASMA LEVELS DOES NOT PREDICT CLINICAL RESPONSE TO BOSENTAN IN PULMONARY ARTERIAL HYPERTENSION. CHEST Journal. 128(4). 202S–202S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Scelsi Breakdown of academic impact, for papers by Edmund Lau Breakdown of academic impact, for papers by Henning Gall Breakdown of academic impact, for papers by Michele D’Alto Breakdown of academic impact, for papers by Karl Dujardin Breakdown of academic impact, for papers by François Kerbaul Breakdown of academic impact, for papers by Frédéric Bodin Breakdown of academic impact, for papers by Elke S. Hoendermis Breakdown of academic impact, for papers by Takeyoshi Kunieda Breakdown of academic impact, for papers by Jaap J. Kloek
Rankless by CCL
2026